Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 176 of 1,261

  1. US 11732025

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  2. US 11732265

    Compositions and methods for modulating complement factor B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  3. US 11733191

    Closed-loop controlled chemical apparatus

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  4. US 11732041

    Antibodies against 4G7-derived chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  5. US 11730819

    Peptide derivatives having novel linkage structures

    BicycleTx Limited · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  6. US 11732024

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  7. US 11732007

    Therapeutic compounds and methods

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  8. US 11732005

    Peptidomimetic proteasome inhibitors

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  9. US 11730150

    Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  10. US 11730705

    Small molecule CMKLR1 antagonists in inflammatory disease

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  11. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  12. US 11730828

    Gene therapy for haploinsufficiency

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  13. WO 2023154894

    COMPOSITIONS ET PROCÉDÉS D'IMMUNOTHÉRAPIE ANTICANCÉREUSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 17, 2023 · Expires Aug 12, 2043

    granted

  14. US 11723982

    Methods of treating an ocular disease or disorder

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  15. US 11723922

    CXCR6-transduced T cells for targeted tumor therapy

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  16. US 11723952

    Methods and compositions for treating Huntington's Disease

    Sangamo Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  17. US 11723943

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  18. US 11723873

    Oral dosage form of ticagrelor and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  19. US 11724987

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  20. US 11723923

    Methods of preparing T cells for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  21. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  22. US 11723949

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  23. US 11723961

    Maspin, maspin derivatives, and maspin mimetics for reducing ROS, inflammation, and skin aging

    Northwestern University · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  24. US 11723635

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.